-
Loading metrics
The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors
- Eun-Jeong Yu,
- Daphne W. Bell
x
- Published: November 22, 2024
- https://doi.org/10.1371/journal.pone.0312806